Diabetic microvascular disease: an endocrine society scientific statement

EJ Barrett, Z Liu, M Khamaisi, GL King… - The Journal of …, 2017 - academic.oup.com
Both type 1 and type 2 diabetes adversely affect the microvasculature in multiple organs.
Our understanding of the genesis of this injury and of potential interventions to prevent, limit …

Bioinorganic chemistry of Alzheimer's disease

KP Kepp - Chemical reviews, 2012 - ACS Publications
Alzheimer's disease (AD) 1− 3 is the most common form of dementia (estimated∼ 50− 60%
of all cases), associated with loss of memory (in particular episodic memory), cognitive …

Multi-target-directed ligands in Alzheimer's disease treatment

M Bajda, N Guzior, M Ignasik… - Current medicinal …, 2011 - ingentaconnect.com
Among the various drug discovery methods, a very promising modern approach consists in
designing multi-target-directed ligands (MTDLs). This methodology has been specifically …

Alzheimer's disease due to loss of function: A new synthesis of the available data

KP Kepp - Progress in neurobiology, 2016 - Elsevier
Alzheimer's Disease (AD) is a highly complex disease involving a broad range of clinical,
cellular, and biochemical manifestations that are currently not understood in combination …

Synaptosome microRNAs regulate synapse functions in Alzheimer's disease

S Kumar, E Orlov, P Gowda, C Bose… - NPJ genomic …, 2022 - nature.com
MicroRNAs (miRNAs) are found in nerve terminals, synaptic vesicles, and synaptosomes,
but it is unclear whether synaptic and cytosolic miRNA populations differ in Alzheimer's …

[HTML][HTML] MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease

S Kumar, H Morton, N Sawant, E Orlov, LE Bunquin… - Redox biology, 2021 - Elsevier
Abstract Background MicroRNA-455-3p is one of the highly conserved miRNAs involved in
multiple cellular functions in humans and we explored its relevance to learning and memory …

Altered serum levels of adipokines and insulin in probable Alzheimer's disease

VK Khemka, D Bagchi… - Journal of …, 2014 - content.iospress.com
Cerebral hypometabolism of glucose, weight loss, and decreased food intake are
characteristic features of sporadic Alzheimer's disease (AD). A systematic study on the …

The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner …

B Maloney, DK Lahiri - Gene, 2011 - Elsevier
Deposition of extracellular plaques, primarily consisting of amyloid β peptide (Aβ), in the
brain is the confirmatory diagnostic of Alzheimer's disease (AD); however, the physiological …

Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating …

JA Bailey, B Maloney, YW Ge, DK Lahiri - Gene, 2011 - Elsevier
Amyloid-β peptide (Aβ) plaque in the brain is the primary (post mortem) diagnostic criterion
of Alzheimer's disease (AD). The physiological role (s) of Aβ are poorly understood. We …

Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells

S Brunholz, S Sisodia, A Lorenzo, C Deyts… - Experimental brain …, 2012 - Springer
Over two decades have passed since the original discovery of amyloid precursor protein
(APP). While physiological function (s) of APP still remain a matter of debate, consensus …